EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and safety of drug-coated balloon angioplasty in proximal LAD stenosis with distal myocardial bridge: a 12-month comparative study with drug-eluting stents

Xi Wu, Mingxing Wu, Haobo Huang, Zhe Liu, He Huang, Lei Wang

Frontiers in Cardiovascular Medicine · 23.07.2025 · 12

DOI: 10.3389/fcvm.2025.1648215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 23.07.2025. Verfasst von Xi Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan, Hunan, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Myocardial bridge (MB), particularly involving the distal left anterior descending artery (LAD), presents unique challenges in percutaneous coronary intervention (PCI) when coexisting with proximal LAD stenosis. Drug-coated balloon (DCB) represents a “leave nothing behind” strategy that may offer advantages over drug-eluting stents (DES) in these anatomically complex lesions.

Methods

In this retrospective single-center study, 231 patients with proximal LAD stenosis and distal MB underwent PCI using either DCB ( n = 83) or DES ( n = 148). Intravascular ultrasound (IVUS)-guided lesion preparation and quantitative coronary angiography (QCA) were used. Clinical and angiographic outcomes were assessed at 12-month follow-up.

Results

Baseline characteristics were comparable between groups. DES achieved greater acute lumen gain (1.94 ± 0.26 mm vs. 1.58 ± 0.36 mm; p < 0.001), while DCB resulted in significantly lower late lumen loss (−0.04 ± 0.04 mm vs. 0.18 ± 0.05 mm; p < 0.001). The incidence of major adverse cardiovascular events (MACE) was lower in the DCB group (9.6% vs. 21.6%; p = 0.033), as was target lesion revascularization (7.2% vs. 18.2%; p = 0.035).

Conclusion

DCB angioplasty is a safe and effective alternative to DES in proximal LAD lesions complicated by distal MB. Despite reduced acute lumen gain, DCBs yielded comparable angiographic results, reduced restenosis and MACE, and enabled shorter dual antiplatelet therapy duration.

Schlagwörter

Stichwörter der Autor:innen

drug-coated balloondrug-eluting stentleft anterior descendingmyocardial bridgepercutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Cardiology, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan, Hunan, China.

Zitieren

APA

Wu, X., Wu, M., Huang, H., Liu, Z., Huang, H., & Wang, L. (2025). Efficacy and safety of drug-coated balloon angioplasty in proximal LAD stenosis with distal myocardial bridge: a 12-month comparative study with drug-eluting stents. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1648215

Vancouver

Wu X, Wu M, Huang H, Liu Z, Huang H, Wang L. Efficacy and safety of drug-coated balloon angioplasty in proximal LAD stenosis with distal myocardial bridge: a 12-month comparative study with drug-eluting stents. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1648215

BibTeX
@article{Wu2025,
  author = {Wu, Xi and Wu, Mingxing and Huang, Haobo and Liu, Zhe and Huang, He and Wang, Lei},
  title = {Efficacy and safety of drug-coated balloon angioplasty in proximal LAD stenosis with distal myocardial bridge: a 12-month comparative study with drug-eluting stents},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fcvm.2025.1648215}
}
Kostenlos starten →